Suppr超能文献

体外多能间充质基质细胞免疫抑制作用的调控因素。

Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

作者信息

Gornostaeva Aleksandra, Andreeva Elena, Buravkova Ludmila

机构信息

Institute of Biomedical Problems of RAS, Khoroshevskoye Shosse, 76 a, Moscow, Russia, 123007.

出版信息

Cytotechnology. 2016 Aug;68(4):565-77. doi: 10.1007/s10616-015-9906-5. Epub 2015 Aug 13.

Abstract

Multipotent mesenchymal stem/stromal cells (MSCs) are of great interest to researchers because of the unique properties, such as enhanced proliferation, paracrine activity and multilineage differentiation. Their non-immunogenicity, in combination with immunomodulatory properties, opens up the opportunity for the allogeneic application of MSCs. The MSC immunomodulatory capacity is currently being actively studied in vitro using various experimental designs. However, the results are not always univocal. It was found that the outcome of the stromal/immune cell interaction depends on experimental conditions. In this review we considered the impact of different factors, such as the ratio of stromal/immune cells, interaction time, the path of immune cell activation, etc. on the MSC immunomodulation. We also accentuated the importance of local milieu, in particular, oxygen tension, for the realization of MSC immunosuppressive activity.

摘要

多能间充质干细胞(MSCs)因其独特的特性,如增强的增殖能力、旁分泌活性和多谱系分化能力,而备受研究人员关注。它们的非免疫原性,结合免疫调节特性,为MSCs的同种异体应用提供了机会。目前正在体外使用各种实验设计积极研究MSCs的免疫调节能力。然而,结果并不总是一致的。发现基质/免疫细胞相互作用的结果取决于实验条件。在本综述中,我们考虑了不同因素,如基质/免疫细胞的比例、相互作用时间、免疫细胞激活途径等对MSCs免疫调节的影响。我们还强调了局部微环境,特别是氧张力,对于实现MSCs免疫抑制活性的重要性。

相似文献

1
Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.
Cytotechnology. 2016 Aug;68(4):565-77. doi: 10.1007/s10616-015-9906-5. Epub 2015 Aug 13.
2
Interaction of multipotent mesenchymal stromal and immune cells: Bidirectional effects.
Cytotherapy. 2017 Oct;19(10):1152-1166. doi: 10.1016/j.jcyt.2017.07.001. Epub 2017 Aug 16.
3
Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Vet Immunol Immunopathol. 2016 Mar;171:57-65. doi: 10.1016/j.vetimm.2016.02.007. Epub 2016 Feb 12.
4
Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects.
Transfus Med Rev. 2016 Jan;30(1):37-43. doi: 10.1016/j.tmrv.2015.11.004. Epub 2015 Dec 1.
5
Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Cytotherapy. 2014 Mar;16(3):331-45. doi: 10.1016/j.jcyt.2013.09.004. Epub 2013 Nov 9.
6
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System.
Stem Cells Int. 2019 Aug 5;2019:7219297. doi: 10.1155/2019/7219297. eCollection 2019.
7
Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Transplantation. 2008 Dec 15;86(11):1586-95. doi: 10.1097/TP.0b013e31818bd96f.
9
Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas.
Cytotherapy. 2014 Jan;16(1):64-73. doi: 10.1016/j.jcyt.2013.07.006. Epub 2013 Oct 1.
10
Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro.
J Tissue Eng Regen Med. 2013 Nov;7(11):921-4. doi: 10.1002/term.1500. Epub 2012 May 18.

引用本文的文献

2
Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro.
Stem Cell Rev Rep. 2024 Jan;20(1):175-205. doi: 10.1007/s12015-023-10654-7. Epub 2023 Nov 14.
4
Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells.
PLoS One. 2020 Jan 3;15(1):e0227174. doi: 10.1371/journal.pone.0227174. eCollection 2020.
5
Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.
Technology (Singap World Sci). 2016 Sep;4(3):201-215. doi: 10.1142/S2339547816500084.
6
Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke.
Exp Ther Med. 2018 May;15(5):4067-4079. doi: 10.3892/etm.2018.5993. Epub 2018 Mar 22.

本文引用的文献

1
Mesenchymal stem cells: immune evasive, not immune privileged.
Nat Biotechnol. 2014 Mar;32(3):252-60. doi: 10.1038/nbt.2816. Epub 2014 Feb 23.
2
Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.
Stem Cells Dev. 2014 Jun 1;23(11):1258-65. doi: 10.1089/scd.2013.0537. Epub 2014 Mar 4.
3
Gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density.
PLoS One. 2014 Jan 6;9(1):e83363. doi: 10.1371/journal.pone.0083363. eCollection 2014.
5
Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.
6
Effect of ex vivo culture conditions on immunosuppression by human mesenchymal stem cells.
Biomed Res Int. 2013;2013:154919. doi: 10.1155/2013/154919. Epub 2013 Jun 4.
7
[Alteration of MMSC's immunosupression at reduced o2: direct cell-to-cell contacts and paracrine regulation].
Fiziol Cheloveka. 2013 Mar-Apr;39(2):31-42. doi: 10.7868/s0131164613020057.
8
On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation.
Front Immunol. 2012 May 18;3:126. doi: 10.3389/fimmu.2012.00126. eCollection 2012.
9
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.
Stem Cells Dev. 2012 Oct 10;21(15):2770-8. doi: 10.1089/scd.2012.0176. Epub 2012 Jul 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验